Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Dr. Reddy's Laboratories Ltd (NY: RDY )

60.65 USD +0.68 (+1.13%)
Streaming Delayed Price Updated: 11:20 AM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 20,358
Open 60.64
Bid (Size) 60.66 (1)
Ask (Size) 60.76 (4)
Prev. Close 59.97
Today's Range 60.26 - 61.01
52wk Range 33.33 - 73.50
Shares Outstanding 165,999,034
Dividend Yield 0.46%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
Pomerantz LLP is investigating claims on behalf of investors of Dr. Reddy's Laboratories Limited ("Dr. Reddy's" or the "Company") (NYSE: RDY). Such investors are advised to contact Robert S. Willoughby... 
From PR Newswire
Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Lansoprazole DR... 
From Business Wire News Releases

Performance

YTD
-14.84%
-14.84%
1 Month
-1.03%
-1.03%
3 Month
-7.53%
-7.53%
6 Month
+4.26%
+4.26%
1 Year
+51.13%
+51.13%

More News

Read More
Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V
From Business Wire News Releases
Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market
From Business Wire News Releases
Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market
From Business Wire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dr. Reddy's Laboratories Limited - RDY
From PR Newswire
Dr. Reddy's Starts EUA Process For Russia's Sputnik V COVID-19 Vaccine In India
Tags Biotech News RDY
From Benzinga
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market
From Business Wire News Releases
Dr. Reddy’s Q3 & 9M FY21 Financial Results
From Business Wire News Releases
10 Biggest Price Target Changes For Tuesday
Tags Small Cap Analyst Ratings TMO
From Benzinga
Lots Of News Day
Tags Stocks / Equities
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.